STOK Insider Trading

Insider Ownership Percentage: 11.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $70,103,910.82

Stoke Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Stoke Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Stoke Therapeutics Share Price & Price History

Current Price: $10.68
Price Change: Price Increase of +0.05 (0.47%)
As of 02/14/2025 05:00 PM ET

This chart shows the closing price history over time for STOK up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Stoke Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/9/2024Barry TichoInsiderSell2,586$12.99$33,592.1444,746View SEC Filing Icon  
12/9/2024Edward M Md KayeCEOSell6,786$12.99$88,150.1461,885View SEC Filing Icon  
12/9/2024Jonathan AllanGeneral CounselSell13,666$13.61$185,994.2621,476View SEC Filing Icon  
12/6/2024Barry TichoInsiderSell13,945$12.78$178,217.1047,332View SEC Filing Icon  
12/6/2024Edward M Md KayeCEOSell6,170$12.78$78,852.6068,671View SEC Filing Icon  
12/6/2024Jonathan AllanGeneral CounselSell9,696$12.78$123,914.8835,142View SEC Filing Icon  
12/2/2024Barry TichoInsiderSell10,000$12.07$120,700.0051,277View SEC Filing Icon  
9/19/2024Skorpios TrustMajor ShareholderSell1,937,500$14.05$27,221,875.008,906,181View SEC Filing Icon  
7/1/2024Barry TichoInsiderSell10,000$13.75$137,500.002,485View SEC Filing Icon  
4/17/2024Skorpios TrustMajor ShareholderSell3,600,000$11.60$41,760,000.0010,843,681View SEC Filing Icon  
3/28/2024Jonathan AllanGeneral CounselSell5,126$13.20$67,663.202,598View SEC Filing Icon  
3/19/2024Edward M Md KayeCEOSell11,150$6.10$68,015.0069,350View SEC Filing Icon  
3/19/2024Jonathan AllanGeneral CounselSell2,349$6.10$14,328.907,724View SEC Filing Icon  
3/19/2024Stephen J TulipanoCFOSell4,116$6.10$25,107.6020,746View SEC Filing Icon  
2/1/2024Barry TichoInsiderSell10,000$4.80$48,000.006,981View SEC Filing Icon  
1/2/2024Barry TichoInsiderSell10,000$5.74$57,400.0016,981View SEC Filing Icon  
7/3/2023Barry TichoInsiderSell15,000$10.60$159,000.0025,895View SEC Filing Icon  
6/21/2023Jonathan AllanGeneral CounselSell1,948$13.48$26,259.04View SEC Filing Icon  
6/1/2023Barry TichoInsiderSell15,000$11.13$166,950.0040,895View SEC Filing Icon  
5/3/2023Barry TichoInsiderSell24,697$10.14$250,427.5856,548View SEC Filing Icon  
5/1/2023Barry TichoInsiderSell24,967$10.00$249,670.0086,758View SEC Filing Icon  
2/6/2023Barry TichoInsiderSell9,235$10.02$92,534.70111,725View SEC Filing Icon  
2/2/2023Barry TichoInsiderSell267$10.00$2,670.00124,723View SEC Filing Icon  
1/31/2023Barry TichoInsiderSell200$10.00$2,000.00130,695View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Stoke Therapeutics (NASDAQ:STOK)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at STOK by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Stoke Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/17/2025UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC95,505$1.05M0.0%+123.7%0.180%Search for SEC Filing on Google Icon
2/17/2025Voloridge Investment Management LLC86,888$0.96M0.0%-29.4%0.164%Search for SEC Filing on Google Icon
2/17/2025Squarepoint Ops LLC120,242$1.33M0.0%+6.7%0.227%Search for SEC Filing on Google Icon
2/17/2025Two Sigma Investments LP53,950$0.60M0.0%-53.8%0.102%Search for SEC Filing on Google Icon
2/17/2025Tang Capital Management LLC300,000$3.31M0.2%N/A0.566%Search for SEC Filing on Google Icon
2/17/2025Toronto Dominion Bank3,173,258$35M0.1%N/A5.991%Search for SEC Filing on Google Icon
2/17/2025RTW Investments LP5,123,525$56.51M0.9%+10.1%9.673%Search for SEC Filing on Google Icon
2/17/2025Rafferty Asset Management LLC67,227$0.74M0.0%-18.8%0.127%Search for SEC Filing on Google Icon
2/17/2025Redmile Group LLC4,593,629$50.67M3.5%-2.5%8.672%Search for SEC Filing on Google Icon
2/17/2025ProShare Advisors LLC12,626$0.14M0.0%N/A0.024%Search for SEC Filing on Google Icon
2/17/2025MPM Bioimpact LLC685,826$7.57M1.1%+43.0%1.295%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC76,829$0.85M0.0%+417.9%0.145%Search for SEC Filing on Google Icon
2/17/2025Group One Trading LLC104,411$1.15M0.0%+2.8%0.197%Search for SEC Filing on Google Icon
2/17/2025Graham Capital Management L.P.18,634$0.21M0.0%+8.5%0.035%Search for SEC Filing on Google Icon
2/17/2025Granahan Investment Management LLC567,689$6.26M0.3%-12.0%1.072%Search for SEC Filing on Google Icon
2/17/2025D. E. Shaw & Co. Inc.28,043$0.31M0.0%-83.6%0.053%Search for SEC Filing on Google Icon
2/17/2025Deutsche Bank AG350,614$3.87M0.0%-24.2%0.662%Search for SEC Filing on Google Icon
2/17/2025DAFNA Capital Management LLC171,097$1.89M0.5%-17.5%0.323%Search for SEC Filing on Google Icon
2/17/2025Baker BROS. Advisors LP4,633,838$51.11M0.5%+6.1%8.748%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE9,091$100K0.0%-92.7%0.017%Search for SEC Filing on Google Icon
2/17/2025BNP Paribas Financial Markets4,422$49K0.0%-94.2%0.008%Search for SEC Filing on Google Icon
2/17/2025Ameriprise Financial Inc.10,527$0.12M0.0%-26.5%0.020%Search for SEC Filing on Google Icon
2/14/2025Jane Street Group LLC11,977$0.13M0.0%-96.4%0.023%Search for SEC Filing on Google Icon
2/14/2025Freestone Grove Partners LP18,049$0.20M0.0%N/A0.034%Search for SEC Filing on Google Icon
2/14/2025Schonfeld Strategic Advisors LLC291,795$3.22M0.0%N/A0.551%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp350,788$3.87M0.0%+3.4%0.662%Search for SEC Filing on Google Icon
2/14/2025Tudor Investment Corp ET AL18,258$0.20M0.0%N/A0.034%Search for SEC Filing on Google Icon
2/14/2025Gilder Gagnon Howe & Co. LLC92,546$1.02M0.0%+2.0%0.175%Search for SEC Filing on Google Icon
2/14/2025Price T Rowe Associates Inc. MD37,455$0.41M0.0%+6.3%0.071%Search for SEC Filing on Google Icon
2/14/2025Tower Research Capital LLC TRC 11,930$0.13M0.0%+70.1%0.023%Search for SEC Filing on Google Icon
2/14/2025Dimensional Fund Advisors LP538,900$5.94M0.0%+103.4%1.017%Search for SEC Filing on Google Icon
2/13/2025CANADA LIFE ASSURANCE Co9,716$0.11M0.0%-14.4%0.018%Search for SEC Filing on Google Icon
2/13/2025Marshall Wace LLP951,432$10.49M0.0%-43.1%1.796%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC129,043$1.42M0.0%N/A0.244%Search for SEC Filing on Google Icon
2/13/2025Legal & General Group Plc35,347$0.39M0.0%-5.7%0.067%Search for SEC Filing on Google Icon
2/13/2025Invesco Ltd.12,065$0.13M0.0%N/A0.023%Search for SEC Filing on Google Icon
2/13/2025Wells Fargo & Company MN16,786$0.19M0.0%+51.2%0.032%Search for SEC Filing on Google Icon
2/12/2025Trexquant Investment LP103,031$1.14M0.0%-36.3%0.195%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC877,095$9.68M0.0%+0.7%1.656%Search for SEC Filing on Google Icon
2/12/2025Wellington Management Group LLP134,812$1.49M0.0%-1.6%0.255%Search for SEC Filing on Google Icon
2/12/2025Norges Bank314,800$3.47M0.0%N/A0.594%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.19,964$0.22M0.0%+29.2%0.038%Search for SEC Filing on Google Icon
2/11/2025EntryPoint Capital LLC31,968$0.35M0.1%N/A0.060%Search for SEC Filing on Google Icon
2/11/2025Corebridge Financial Inc.17,861$0.20M0.0%-6.1%0.034%Search for SEC Filing on Google Icon
2/11/2025Vanguard Group Inc.2,731,198$30.13M0.0%-1.0%5.156%Search for SEC Filing on Google Icon
2/11/2025KLP Kapitalforvaltning AS5,700$63K0.0%N/A0.011%Search for SEC Filing on Google Icon
2/11/2025Teacher Retirement System of Texas10,219$0.11M0.0%N/A0.019%Search for SEC Filing on Google Icon
2/10/2025Swiss National Bank67,300$0.74M0.0%+20.4%0.127%Search for SEC Filing on Google Icon
2/6/2025Charles Schwab Investment Management Inc.342,129$3.77M0.0%+8.2%0.646%Search for SEC Filing on Google Icon
2/5/2025Skorpios Trust6,906,181$76.18M99.8%-22.5%13.038%Search for SEC Filing on Google Icon
2/4/2025Los Angeles Capital Management LLC43,438$0.48M0.0%-57.8%0.082%Search for SEC Filing on Google Icon
2/4/2025Bank of New York Mellon Corp93,195$1.03M0.0%+1.4%0.176%Search for SEC Filing on Google Icon
1/30/2025Rhumbline Advisers49,374$0.55M0.0%+6.0%0.093%Search for SEC Filing on Google Icon
1/24/2025China Universal Asset Management Co. Ltd.11,231$0.12M0.0%N/A0.021%Search for SEC Filing on Google Icon
1/17/2025SG Americas Securities LLC10,768$0.12M0.0%-27.8%0.020%Search for SEC Filing on Google Icon
1/14/2025Assenagon Asset Management S.A.1,350,925$14.90M0.0%+2.9%2.551%Search for SEC Filing on Google Icon
12/13/2024Exome Asset Management LLC176,600$2.17M1.5%N/A0.333%Search for SEC Filing on Google Icon
11/27/2024Franklin Resources Inc.22,314$0.29M0.0%-98.2%0.042%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC79,740$0.98M0.0%+145.3%0.151%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC870,831$10.71M0.0%+9.7%1.644%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC79,740$0.98M0.0%+145.3%0.151%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC330,442$4.06M0.0%+338.2%0.624%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP136,975$1.68M0.0%-4.6%0.259%Search for SEC Filing on Google Icon
11/15/2024State Street Corp1,728,888$21.25M0.0%+8.6%3.264%Search for SEC Filing on Google Icon
11/15/2024RTW Investments LP4,652,285$57.18M0.8%+10.1%8.783%Search for SEC Filing on Google Icon
11/15/2024Redmile Group LLC4,713,509$57.93M3.4%-0.2%8.898%Search for SEC Filing on Google Icon
11/15/2024Checkpoint Capital L.P.157,514$1.94M1.0%N/A0.297%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC42,692$0.53M0.0%-25.6%0.081%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets76,154$0.94M0.0%+1,589.7%0.144%Search for SEC Filing on Google Icon
11/13/2024FMR LLC322,949$3.97M0.0%-18.9%0.610%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.316,134$3.89M0.0%+9.3%0.597%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC13,052$0.16M0.0%N/A0.025%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC103,005$1.27M0.0%+54.3%0.196%Search for SEC Filing on Google Icon
11/2/2024Mesirow Financial Investment Management Inc.15,604$0.19M0.0%N/A0.030%Search for SEC Filing on Google Icon
10/23/2024Skorpios Trust8,906,181$109.46M99.8%-17.9%16.916%Search for SEC Filing on Google Icon
10/23/2024Assenagon Asset Management S.A.1,312,479$16.13M0.0%-10.6%2.493%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC14,917$0.18M0.0%-78.3%0.029%Search for SEC Filing on Google Icon
9/20/2024Healthcare of Ontario Pension Plan Trust Fund1,387,200$18.74M0.1%+426.1%2.635%Search for SEC Filing on Google Icon
9/4/2024Ghisallo Capital Management LLC15,000$0.20M0.0%-50.0%0.028%Search for SEC Filing on Google Icon
8/15/2024Lynx1 Capital Management LP5,185,191$70.05M25.3%+40.3%9.848%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company13,964$0.19M0.0%+16.7%0.027%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC289,067$3.91M0.0%+528.6%0.549%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC15,042$0.20M0.0%-70.6%0.029%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP1,161,037$15.69M0.0%+550.1%2.205%Search for SEC Filing on Google Icon
8/14/2024Logos Global Management LP1,050,000$14.19M1.1%N/A1.994%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC14,893$0.20M0.0%N/A0.028%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC11,200$0.15M0.0%-41.4%0.021%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP191,360$2.59M0.0%-12.9%0.367%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.59,149$0.80M0.0%+99.4%0.113%Search for SEC Filing on Google Icon
8/6/2024Quest Partners LLC2,110$29K0.0%N/A0.004%Search for SEC Filing on Google Icon
8/6/2024Los Angeles Capital Management LLC66,765$0.90M0.0%+7.2%0.128%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers47,860$0.65M0.0%+14.3%0.092%Search for SEC Filing on Google Icon
7/29/2024Zurcher Kantonalbank Zurich Cantonalbank9,129$0.12M0.0%N/A0.018%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp115,892$1.57M0.0%+28.9%0.222%Search for SEC Filing on Google Icon
7/20/2024Nisa Investment Advisors LLC2,989$40K0.0%+53.2%0.006%Search for SEC Filing on Google Icon
7/18/2024Assenagon Asset Management S.A.1,468,202$19.84M0.0%N/A2.817%Search for SEC Filing on Google Icon
7/12/2024SG Americas Securities LLC68,601$0.93M0.0%+610.3%0.132%Search for SEC Filing on Google Icon
5/30/2024Lynx1 Capital Management LP3,696,820$49.91M12.9%+25.0%7.093%Search for SEC Filing on Google Icon
5/17/2024Artal Group S.A.300,000$4.05M0.1%N/A0.576%Search for SEC Filing on Google Icon
5/17/2024Ikarian Capital LLC6,816$92K0.0%-43.7%0.013%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Stoke Therapeutics logo
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary targeted augmentation of nuclear gene output to develop antisense oligonucleotides to selectively restore protein levels. Its lead clinical candidate is STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy. The company also develops STK-001, which is in phase I/II clinical trial to treat Dravet syndrome; and programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye. The company has a license and collaboration agreement with Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of severe and rare genetic neurodevelopmental diseases of the central nervous system. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.
Read More on Stoke Therapeutics

Today's Range

Now: $10.68
Low: $10.58
High: $11.07

50 Day Range

MA: $10.84
Low: $8.68
High: $13.26

52 Week Range

Now: $10.68
Low: $4.92
High: $17.58

Volume

349,303 shs

Average Volume

805,888 shs

Market Capitalization

$565.72 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.95

Who are the company insiders with the largest holdings of Stoke Therapeutics?

Stoke Therapeutics' top insider shareholders include:
  1. Skorpios Trust (Major Shareholder)
  2. Barry Ticho (Insider)
  3. Edward M Md Kaye (CEO)
  4. Jonathan Allan (General Counsel)
  5. Stephen J Tulipano (CFO)
Learn More about top insider investors at Stoke Therapeutics.

Who are the major institutional investors of Stoke Therapeutics?

Stoke Therapeutics' top institutional shareholders include:
  1. Skorpios Trust — 13.04%
  2. RTW Investments LP — 9.67%
  3. Baker BROS. Advisors LP — 8.75%
  4. Redmile Group LLC — 8.67%
  5. Toronto Dominion Bank — 5.99%
  6. Vanguard Group Inc. — 5.16%
Learn More about top institutional investors of Stoke Therapeutics stock.

Which institutional investors are selling Stoke Therapeutics stock?

During the last quarter, STOK stock was sold by these institutional investors:
  1. Skorpios Trust
  2. Marshall Wace LLP
  3. Jane Street Group LLC
  4. D. E. Shaw & Co. Inc.
  5. Redmile Group LLC
  6. Bank of America Corp DE
  7. Deutsche Bank AG
  8. Granahan Investment Management LLC
During the last year, company insiders that have sold Stoke Therapeutics company stock include:
  1. Skorpios Trust (Major Shareholder)
  2. Barry Ticho (Insider)
  3. Edward M Md Kaye (CEO)
  4. Jonathan Allan (General Counsel)
  5. Stephen J Tulipano (CFO)
Learn More investors selling Stoke Therapeutics stock.

Which institutional investors are buying Stoke Therapeutics stock?

In the last quarter, STOK stock was purchased by institutional investors including:
  1. Toronto Dominion Bank
  2. RTW Investments LP
  3. Norges Bank
  4. Tang Capital Management LLC
  5. Schonfeld Strategic Advisors LLC
  6. Dimensional Fund Advisors LP
  7. Baker BROS. Advisors LP
  8. MPM Bioimpact LLC